A Treatment Option for Metastatic Colorectal Cancer Patients with BRAFV600E Mutation in Singapore
Pierre Fabre Singapore receives approval from the Ministry of Health (“MOH”), Singapore, for the listing of BRAFTOVI on the Cancer Drug List (“CDL”)¹. An approved therapeutic product registered with Health…